Jun 08, 2023 / 01:30PM GMT
Eun Yang - Jefferies Group (Trades, Portfolio) LLC - Analyst
Good evening, everyone. This is Eun Yang, a biotech analyst with Jefferies. I'm happy to have a fireside chat with Cogent CEO, Andy Robbins.
Andy, before we start the Q&A, could you give us a quick overview of what Cogent does?
Andy Robbins - Cogent Biosciences, Inc. - CEO & President
Sure then. Eun, thanks so much for inviting us to the conference today. Happy to be here even with a smog. So hopefully, excuse my gravelly throat today.
Before I do the intro, just to remind folks for a better and more full characterization of risks to take a look at our SEC disclosures as I probably will be making some forward-looking statements today.
So for those that aren't as familiar with the
Cogent Biosciences Inc at Jefferies Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
